| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 8.1% | -16% | $135,978,768 | -$23,753,077 | 7,130,507 | -15% | BlackRock, Inc. | 31 Mar 2025 |
| JANUS HENDERSON GROUP PLC | 7.3% | +5.7% | $174,915,104 | +$6,043,368 | 6,428,339 | +3.6% | JANUS HENDERSON GROUP PLC | 30 Sep 2025 |
| Capital Research Global Investors | 6% | -19% | $194,503,227 | -$46,897,909 | 5,279,675 | -19% | Capital Research Global Investors | 31 Dec 2025 |
| FEDERATED HERMES, INC. | 3.9% | $117,393,162 | 3,395,771 | Federated Hermes, Inc. | 31 Dec 2025 | |||
| Point72 Asset Management, L.P. | 2.1% | -58% | $67,953,443 | -$94,600,552 | 1,844,556 | -58% | Point72 Asset Management, L.P. | 31 Dec 2025 |
As of 31 Dec 2025, 238 institutional investors reported holding 95,859,713 shares of IDEAYA Biosciences, Inc. - Common Stock, par value $0.0001 per share (IDYA). This represents 109% of the company’s total 87,836,000 outstanding shares.
The largest institutional shareholders of IDEAYA Biosciences, Inc. - Common Stock, par value $0.0001 per share (IDYA) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 15% | 13,149,960 | +0.03% | 0.02% | $454,594,125 |
| BlackRock, Inc. | 9.3% | 8,209,392 | +1% | 0% | $283,798,682 |
| JANUS HENDERSON GROUP PLC | 8.2% | 7,186,456 | +12% | 0.11% | $248,344,296 |
| Capital Research Global Investors | 6% | 5,279,675 | -19% | 0.03% | $182,518,365 |
| VANGUARD GROUP INC | 5.7% | 5,019,324 | +2% | 0% | $173,518,031 |
| STATE STREET CORP | 4.7% | 4,134,641 | +28% | 0% | $142,934,539 |
| BAKER BROS. ADVISORS LP | 4.1% | 3,618,826 | +10% | 0.73% | $125,102,815 |
| FEDERATED HERMES, INC. | 3.9% | 3,395,771 | -27% | 0.2% | $117,391,803 |
| Logos Global Management LP | 3.6% | 3,125,000 | +39% | 7.2% | $108,031,250 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.2% | 2,800,000 | -3.5% | 0.15% | $96,796,000 |
| Fiera Capital Corp | 2.8% | 2,437,262 | +33% | 0.27% | $84,256,148 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.5% | 2,153,043 | 0% | 0.95% | $74,430,697 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 2,073,583 | -3.6% | 0% | $71,694,992 |
| Point72 Asset Management, L.P. | 2.1% | 1,844,556 | -52% | 0.1% | $63,766,301 |
| GOLDMAN SACHS GROUP INC | 2% | 1,770,866 | +44% | 0.01% | $61,218,838 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.6% | 1,449,145 | +31% | 0.01% | $50,098,000 |
| GSK plc | 1.5% | 1,333,333 | 0% | 5.8% | $46,093,322 |
| MORGAN STANLEY | 1.4% | 1,252,403 | -21% | 0% | $43,295,572 |
| UBS Group AG | 1.2% | 1,085,632 | +2.7% | 0.01% | $37,530,298 |
| Candriam S.C.A. | 1.2% | 1,031,354 | +1.8% | 0.18% | $35,655,426 |
| Ensign Peak Advisors, Inc | 1.1% | 979,063 | +30% | 0.06% | $33,846,208 |
| CITADEL ADVISORS LLC | 1.1% | 959,355 | -27% | 0.02% | $33,164,903 |
| DIMENSIONAL FUND ADVISORS LP | 1.1% | 938,857 | +89% | 0.01% | $32,456,177 |
| BANK OF AMERICA CORP /DE/ | 1% | 902,973 | -1.4% | 0% | $31,215,784 |
| Fisher Asset Management, LLC | 1% | 889,633 | +3.2% | 0.01% | $30,754,612 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 95,859,713 | $3,314,382,916 | +$34,390,354 | $34.57 | 238 |
| 2025 Q3 | 94,078,963 | $2,559,895,530 | -$71,222,974 | $27.21 | 221 |
| 2025 Q2 | 96,817,428 | $2,035,216,946 | +$85,041,555 | $21.02 | 201 |
| 2025 Q1 | 93,850,250 | $1,541,886,881 | +$4,216,022 | $16.38 | 204 |
| 2024 Q4 | 91,956,771 | $2,362,946,798 | -$39,164,259 | $25.70 | 204 |
| 2024 Q3 | 91,887,231 | $2,910,570,888 | +$266,023,831 | $31.68 | 208 |
| 2024 Q2 | 82,498,020 | $2,896,457,095 | +$112,714,519 | $35.11 | 197 |
| 2024 Q1 | 79,029,194 | $3,467,731,111 | +$578,501,456 | $43.88 | 202 |
| 2023 Q4 | 66,135,600 | $2,353,088,646 | +$312,448,429 | $35.58 | 155 |
| 2023 Q3 | 59,708,967 | $1,610,925,530 | +$91,466,602 | $26.98 | 143 |
| 2023 Q2 | 56,594,046 | $1,329,917,026 | +$272,378,345 | $23.50 | 138 |
| 2023 Q1 | 45,571,754 | $625,396,958 | -$7,022,953 | $13.73 | 127 |
| 2022 Q4 | 45,969,604 | $835,255,954 | +$24,122,546 | $18.17 | 117 |
| 2022 Q3 | 44,731,101 | $667,335,427 | +$139,348,641 | $14.92 | 111 |
| 2022 Q2 | 35,430,856 | $488,943,386 | +$8,388,194 | $13.80 | 95 |
| 2022 Q1 | 34,963,082 | $391,248,464 | -$45,848,010 | $11.19 | 100 |
| 2021 Q4 | 34,726,651 | $820,669,496 | +$42,947,568 | $23.64 | 108 |
| 2021 Q3 | 32,866,465 | $837,907,234 | +$191,179,767 | $25.49 | 90 |
| 2021 Q2 | 25,401,939 | $533,388,213 | +$25,544,214 | $20.99 | 83 |
| 2021 Q1 | 23,772,357 | $605,123,340 | +$111,002,539 | $23.50 | 87 |
| 2020 Q4 | 20,283,687 | $283,967,278 | +$21,355,133 | $14.00 | 81 |
| 2020 Q3 | 18,878,265 | $237,100,196 | +$3,530,187 | $12.56 | 66 |
| 2020 Q2 | 18,472,023 | $262,487,409 | +$120,236,682 | $14.21 | 64 |
| 2020 Q1 | 10,920,611 | $44,992,000 | -$1,201,515 | $4.12 | 24 |
| 2019 Q4 | 11,151,290 | $83,635,000 | -$5,010,818 | $7.50 | 27 |
| 2019 Q3 | 5,572,657 | $49,467,000 | -$827,584 | $9.00 | 24 |
| 2019 Q2 | 5,653,725 | $56,312,000 | +$56,312,000 | $9.96 | 24 |